AnaptysBio, Inc. (ANAB) Stock Overview
Explore AnaptysBio, Inc.’s financial performance, market position, analyst ratings, and future outlook.
AnaptysBio, Inc. (ANAB)
Key Financials
Key Financials
Market Cap
1.5B
P/E Ratio
7.50
EPS (TTM)
$-1.08
ROE
25.15%
ANAB Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of AnaptysBio, Inc. (NASDAQ: ANAB) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, AnaptysBio, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ANAB on the NASDAQ shows an RSI of 33.55, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $67.41 for the NASDAQ listing.
Key metrics behind AnaptysBio, Inc.'s NASDAQ-traded stock include a P/E ratio of 7.50 and a market capitalization of 1.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ANAB on the NASDAQ.